Susquehanna International Group, LLP Foghorn Therapeutics Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 39,649 shares of FHTX stock, worth $193,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,649
Previous 31,850
24.49%
Holding current value
$193,090
Previous $116,000
60.34%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FHTX
# of Institutions
82Shares Held
37MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$61.7 Million23.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$25.8 Million0.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$15.9 Million0.35% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.37MShares$11.5 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$11.2 Million0.01% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $203M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...